NCT06055023View on ClinicalTrials.gov

Phase I Clinical Study of ZL-82 Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

April 9, 2023

Primary Completion Date

January 28, 2024

Study Completion Date

June 13, 2024

Conditions
Rheumatoid Arthritis (RA)Inflammatory Bowel Disease - IBD1
Interventions
DRUG

ZL-82 12.5mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 25mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 50mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 100mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 200mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 300mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 450mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 600mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

zL-82 placebo 12.5mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 placebo 25mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 placebo 50mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 placebo 100mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 placebo 200mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 placebo 300mg

1 case,The starting dose,Take the medicine once on D1,D1-7. Edit

DRUG

ZL-82 placebo 450mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

DRUG

ZL-82 placebo 600mg

1 case,The starting dose,Take the medicine once on D1,D1-7.

Trial Locations (1)

Unknown

Affiliated Hospital of Guizhou Medical University, Guizhou

All Listed Sponsors
lead

Chengdu Zenitar Biomedical Technology Co., Ltd

INDUSTRY